Zomedica (ZOMD.F) Stock Analysis & Winston Score
Zomedica is a veterinary health company that makes medical devices and products for animals, mainly dogs and cats. Its main product is the TRUFORMA platform, a diagnostic machine that sits in a vet's office and runs tests on pet blood samples to check for hormone and thyroid problems. The company sells directly to veterinary clinics across the United States. Zomedica makes money by selling the TRUFORMA machines to vet clinics and then charging for the test cartridges those machines use — a recurring "razor and blades" model. The company is small, with revenue still in the early growth stage, and it operates primarily in North America. Its main competitive advantage is having a point-of-care diagnostic tool built specifically for veterinary use, but the key risk is that it remains unprofitable and must keep growing its installed base of machines fast enough to reach sustainable cash flow.
Winston Score: 0/100 — Insufficient Data
Not enough data to score this stock reliably.
- Quality: Data not available (0/30)
- Growth: Data not available (0/20)
- Cash Flow: Data not available (0/10)
- Stability: Data not available (0/10)
- Valuation: Data not available (0/10)
- Ownership: Ownership data not available (not counted) (0/15)
